Acid Reducer and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Acid Reducer and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ranitidine
Brand name: Baciguent, Probiotic Formula, Proferrin-ES
Synonyms: n.a.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Acid Reducer-Insulin degludec
- Acid Reducer-Insulin Degludec (U-100) Prefilled Pens
- Acid Reducer-Insulin Degludec (U-100) Vials
- Acid Reducer-Insulin Degludec (U-200) Prefilled Pens
- Acid Reducer-Insulin degludec and liraglutide
- Acid Reducer-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Acid Relief
- Insulin aspart, recombinant Subcutaneous-Aciphex
- Insulin aspart, recombinant Subcutaneous-Aciphex (Rabeprazole Delayed-Release Tablets)
- Insulin aspart, recombinant Subcutaneous-Aciphex (Rabeprazole Sprinkle Capsules)
- Insulin aspart, recombinant Subcutaneous-AcipHex Sprinkle
- Insulin aspart, recombinant Subcutaneous-Acitretin